Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports efficacy and safety results for vortioxetine in adults with major depressive disorder, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18